Skip to content
Sign in
StableHealthReported 2026-11-19 06:00

FDA Approves Drug for Infantile-Onset Niemann-Pick Type C

The FDA has approved cyclodextrin (Adrabetadex) for treating infantile-onset Niemann-Pick type C disease, a rare neurodegenerative disorder, after a clinical trial showed extended survival for participants.

Why it matters. This breakthrough offers new hope to families affected by Niemann-Pick type C, a disease that leads to progressive neurological decline and premature death.

01

Evidence

  • MMedical XpressMedia2026-11-19 06:00
    View source